baber/WOPTO huggingface dataset:
Patent NO-20171977-A1 (NO)
Inventor: BELLO OLADELE
IPC: G06Q50/02
Filed: 2017-12-12
Abstract: A method of online real-time estimation of production performance properties includes receiving real-time field data tåken by downhole sensors, and estimat ing formation properties and Production performance properties by applying the field data to a two or threedimensional numerical transient thermal multiphase reservoir flow model, and automatically calibrating the model. Calibrating includes: selecting calibration parameters corresponding to values of selected model parameters, and applying the calibration parameters to the model to generate predicted properties that correlate with the selected model parameters, the predicted properties including flow rates and/or formation properties; automatically calculating a difference between the predicted properties and measured properties that correlate with the selected model parameters, and calculating an objective function value; performing an inversjon that includes iteratively adjusting the selected model parameters until the objective function reaches a selected minimum value; and automatically updating the model by applying the selected model parameters associated with the minimum value.
Patent NO-20181228-A1 (NO)
Inventor: BENNETT BRUCE RICHARD
IPC: F04D13/10
Filed: 2018-09-20
Abstract: An apparatus, system and method for live well artificial lift completion. A live well artificial lift completion system includes an artificial lift pump discharge, a discharge adapter body secured between the artificial lift pump discharge and an umbilical, the discharge adapter body including an electrical connector fastened to an exterior of the discharge adapter body, an inner diameter of the discharge adapter body fluidly coupled to the artificial lift pump discharge, the umbilical including coiled tubing supportively hanging from an umbilical hanger within a wellhead, the umbilical hanger positioned in a tubing head spool, an inner diameter of the coiled tubing fluidly coupled to the inner diameter of the discharge adapter body, a jacket surrounding the coiled tubing, and a power cable extruded inside the jacket, wherein the power cable is connectable between the electrical connector of the discharge adapter body and a surface Power source.
Patent NO-20181243-A1 (NO)
Inventor: ROBERSON MARK
IPC: G01V3/26
Filed: 2018-09-20
Abstract: Systems and methods using multi-electrode configurations for characterizing fluids in subterranean formations during various treatment operations are provided. In certain embodiments, the methods comprise: placing a tubular base structure having a multi-electrode configuration disposed thereon in at least a portion of a well bore penetrating at least a portion of a subterranean formation, the multi- electrode configuration comprising at least first and second electrodes with a dielectric layer between the tubular base structure and the electrodes; collecting electromagnetic measurements using the multi-electrode configuration; and processing the electromagnetic measurements to obtain a characterization of at least one fluid in an annulus between the tubular base structure and an inner wall of the well bore. The first and second electrodes of the multi-electrode configuration may be oriented along non-parallel planes and/or positioned at different heights from an outer surface of the tubular base structure.
Patent NO-20181489-A1 (NO)
Title: Fremgangsmåte for fremstilling av flerumettede fettsyrer i transgene organismer.
Inventor: HEINZ ERNST
IPC: C12P7/64
Filed: 2018-11-21
Abstract: Foreliggende oppfinnelse angår en fremgangsmåte for produksjon av flerumettede fettsyrer i en organisme ved innføring i organismen, nukleinsyrer som koder for polypeptider med Δ5-elongase-aktivitet.Fordelaktig kan disse nukleinsyresekvenser uttrykkes i organismen, hvis det passer sammen med ytterligere nukleinsyresekvenser som koder for polypeptider av biosyntese av fettsyre- eller lipidmetabolisme. Spesielt fordelaktig er nukleinsyresekvenser som koder for en Δ6-desaturase-, Δ5-desaturase-, Δ4-desaturase- og/eller Δ6-elongase-aktivitet. Disse desaturaser og elongaser er fordelaktig avledet fra Thalassiosira, Euglena eller Ostreococcus. Oppfinnelsen angår videre en fremgangsmåte for fremstilling av oljer og/eller triacylglycerider med et forhøyet innhold av langkjedede flerumettede fettsyrer. I en foretrukket utførelsesform angår foreliggende oppfinnelse videre en metode for fremstilling av umettede ω3-fettsyrer og en metode for fremstilling av triglycerider med et forhøyet innhold av umettede fettsyrer, spesielt ω3-fettsyrer med mer enn tre dobbeltbindinger. Oppfinnelsen angår dannelse av en transgen organisme, fortrinnsvis en transgen plante eller en transgen mikroorganisme, med et forhøyet innhold av umettet ω3-fettsyrer, oljer eller lipider med ω3-dobbeltbindinger som resultat av ekspresjon av elongaser og desaturaser anvendt ved fremgangsmåten ifølge oppfinnelsen, fordelaktig sammen med ω3-desaturaser, for eksempel en ω3-desaturase fra sopper av familien Pythiaceae så som slekten Phytophthora, for eksempel slekten og arten Phytophthora infestans eller en ω3-desaturase fra alger så som familien Prasinophyceae, for eksempel slekten Ostreococcus, spesifikt slekten og arten Ostreococcus tauri eller diatoméer så som slekten Thalassiosira, spesifikt slekten og arten Thalassiosira pseudonana. Oppfinnelsen angår videre nukleinsyresekvenser, nukleinsyrekonstruksjoner, vektorer og organismer omfattende nukleinsyresekvensene ifølge oppfinnelsen, vektorer omfattende nukleinsyresekvensene og/eller nukleinsyrekontruksjonene og transgene organismer omfattende de ovennevnte nukleinsyresekvenser, nukleinsyrekonstruksjoner og/eller vektorer. En ytterligere del av oppfinnelsen angår oljer, lipider og/eller fettsyrer produsert ved fremgangsmåten ifølge oppfinnelsen og anvendelse av dem. Oppfinnelsen angår videre umettede fettsyrer og triglycerider med et forhøyet innhold av umettede fettsyrer og anvendelse av dem.
Patent PE-20000963-A1 (PE)
Title: Tisu resistente al paso del liquido
Inventor: HSU JAY CHIEHLUNG
IPC: B32B29/00
Filed: 1999-06-24
Abstract: EL CUAL COMPRENDE : i) UNA PRIMERA HOJA CELULOSICA QUE COMPRENDE ADEMAS UNA SOLA CAPA; ii) UNA SEGUNDA HOJA CELULOSICA QUE COMPRENDE ADEMAS UNA SOLA CAPA; iii) AL MENOS UNA HOJA QUE SE TRATA CON UN AGENTE REPELENTE,DE PREFERENCIA CERA, LATEX, UN AGENTE ENCOLANTE O UN QUIMICO HIDROFOBICO, A FIN DE CREAR UNA REGION PARA EVITAR QUE EL FLUIDO PASE A TRAVES DEL PRODUCTO DE TISU. ADEMAS, LAS DOS PRIMERAS HOJAS CELULOSICAS PUEDEN COMPRENDER UNA SEGUNDA CAPA, LAS QUE SE COLOCAN ENTRE LAS PRIMERAS CAPAS DE LA HOJAS, Y AL MENOS UNA DE LAS SEGUNDAS CAPAS ES RESISTENTE AL PASO DEL FLUIDO
Patent PE-20001384-A1 (PE)
Title: Derivados de acetamida no peptidicos como antagonistas de receptor de nk1
Inventor: HORWELL DAVID CHRISTOPHER
IPC: A61K31/53
Filed: 1999-12-17
Abstract: SE REFIERE A UN COMPUESTOS DERIVADOS DE ACETAMIDA NO PEPTIDICOS DE FORMULA I, DONDE R ES PIRIDILO, TIENILO, FURILO, PIRROLILO, PIRAZOLILO, QUINOLINILO, ISOQUINOLILO, NAFTILO, ENTRE OTROS; O R1 Y R2 SON H, ALQUILO C1-C4; m ES 0-3; X ES NHCONH, NR8; R8 ES H, ALQUILO C1-C4; R3 ES H, ALQUILO C1-C4; n ES 1-2; R4 ES NAFTILO, INDOLILO; R9 ES H, ALQUILO C1-C4; R5 Y R7 SON H, (CH2)pR10; p ES 1-3; R10 ES H, CH3, CN, OH, OCH3, CO2CH3, NH2, NHCH3, N(CH3)2; q ES 0-4; R6 ES FENILO, PIRIDILO, TIENILO, FURILO, PIRROLILO, ALQUILO C1-C3, CICLOALQUILO C5-C8, ENTRE OTROS; CUANDO R5 Y R6 ESTAN UNIDOS POR UN ENLACE FORMAN UN ANILLO. SON COMPUESTOS PREFERIDOS 2-[(BENZOFURAN-2-ILMETIL)-AMINO]-3-(1H-INDOL-3-IL)-2-METIL-N-(1-FENIL-ETIL)PROPIONAMIDA, [R-(R*,S*)]; 2-[(BENZOFURAN-2-ILMETIL)AMINO]-3-(1H-INDOL-3-IL)-2-METIL-N-(1-PIRIDIN-4-IL-ETIL)-PROPIONAMIDA, [R-(R*,S*)], ENTRE OTROS. EL COMPUESTO I ES UN ANTAGONISTA DEL RECEPTOR NEUROQUININA NK1, POR LO QUE PUEDE SER UTIL PARA EL TRATAMIENTO DE UN TRASTORNO DEL SNC, COMO DOLOR, ANSIEDAD, DEPRESION, ESQUIZOFRENIA, NEURALGIA, STRESS, TRASTORNO ALERGICO O INFLAMATORIO
Patent PE-22996-A1 (PE)
Inventor: SJOGREN ERIC BRIAN
IPC: A61K31/4025
Filed: 1995-02-16
Abstract: The disclosed hexenoic acid side-chain derivatives of mycophenolic acid are therapeutic agents advantageous in the treatment of disease states indicated for mycophenolic acid and/or mycophenolate mofetil, including immune, inflammatory, tumor, proliferative, viral or psoriatic disorders.
Patent PL-219353-A1 (PL)
Inventor: BOWER TERRY F
IPC: B22D11/16
Filed: 1979-10-31
Abstract: Disclosed is apparatus and method for integrated, continuous, high speed manufacture of metallic strip, especially brass, from a melt. The apparatus comprises a chilled casting mold in liquid communication with a melt and means for drawing a rod through the mold in a pattern of forward and reverse strokes. After emergence from the mold, the rod speed is regulated to a substantially constant value before conversion into strip. In this embodiment, the casting mold is stationary; the rod is drawn through the mold by driven rolls programmed to create the desired forward and reverse motion of the rod through the mold. Creating substantially constant speed is accomplished by allowing slack to develop through the lateral deflection of the rod. In another embodiment, the casting mold oscillates as the rod is withdrawn at a substantially constant speed so further rod motion regulation is unnecessary. Conversion of the rod to strip comprises flattening in a hot rolling mill, and quenching. In accordance with known procedures the produced strip can be further reduced in cross section in a cold rolling mill if desired.
Patent PL-299541-A1 (PL)
Title: Novel derivatives of n-[(4-aminocarbonylopyrimidino-2)-aminoalkyl]-2-aminopyrimidine carrbonamide-4, method of obtaining them, drug and pharmaceutical preparation
Inventor: GEORGE PASCAL
IPC: C07D401/14
Filed: 1993-07-01
Abstract: Compounds corresponding to the general formula (I) <IMAGE> in which m represents the number 0 or 1, R1 represents a methyl group, in which case R2 represents a phenoxy(C1-C4)alkyl group, or else R1 and R2 together form, and with the nitrogen atom which carries them, a 4-phenoxy-1-piperidyl (4-phenoxypiperidino) group, a phenoxymethyl-1-piperidyl (phenoxymethylpiperidino) group or a 4-phenyl-1-piperazinyl group, and R3 represents a hydrogen atom or, when n is equal to 1, a hydroxyl group or a methoxy group. Application in therapeutics.
Patent PL-304618-A1 (PL)
Title: Translucent substrate provided with a number of thin superimposed layer for use as thermally insulating and/or antisolar glazing
Inventor: GUISELIN OLIVIER
IPC: C03C27/12
Filed: 1994-08-11
Abstract: Transparent substrate (1), especially of glass, with thin multilayers, on which the following are deposited in succession:     - a first coating of dielectric material (2), - a first layer (3) with properties of reflection in the infrared, especially metal-based,   - a second coating of dielectric material (5), - a second layer (6) with properties of reflection in the infrared, especially metal-based, - a third coating of dielectric material (8), characterised in that the thickness of the first layer with properties of reflection in the infrared (3) corresponds to approximately 50 to 80 %, especially 55 to 75 % and preferably 60 to 70 %, of that of the second layer with properties of reflection in the infrared (6).   <IMAGE>
Patent PL-311722-A1 (PL)
Title: Double-chamber blister package protected against children
Inventor: HAMILTON PETER WORTHINGTON
IPC: A61J7/00
Filed: 1994-05-17
Abstract: A dual chamber-child-resistant blister package is provided. The blisters of the package include a storage chamber and a discharge chamber. In addition, the blister includes restraint means for preventing the medicament from moving from the storage chamber to the discharge chamber until a predetermined force is applied to the blister package. The medicament may not be dispensed directly from the storage chamber, since a nonrupturable layer is located adjacent the storage chamber of the blister. The nonrupturable layer includes an opening, or a mechanism such as a score line for forming and opening) through which the medicament can pass adjacent the discharge chamber. A rupturable layer is also provided to seal the medicament within the blister. Typically, the rupturable layer is located adjacent the nonrupturable layer to seal the opening in the nonrupturable layer. The blister package may also include indicia associated with the blisters to help insure compliance with complex therapeutic regimens. The blister package may also include fold lines to help reduce the overall size of the blister package; thereby making it easier to transport.
Patent PL-311820-A1 (PL)
Title: Fluoroaloxyl-group substituted benzamides and their application as inhibitors of phosphodiesterase of cyclic nucleotides
Inventor: AMSCHLER HERMANN
IPC: A61P37/08
Filed: 1994-07-02
Abstract: PCT No. PCT/EP94/02169 Sec. 371 Date Dec. 19, 1995 Sec. 102(e) Date Dec. 19, 1995 PCT Filed Jul. 2, 1994 PCT Pub. No. WO95/01338 PCT Pub. Date Jan. 12, 1995Compounds of formula (I), in which one of the substituents R1 or R2 stands for hydrogen, 1-6C-alkoxy, 3-7C-cycloalkoxy, 3-7C-cycloalkylmethoxy, benzyloxy or totally or partially fluorine-substituted 1-4C-alkoxy, and the other stands for totally or partially fluorine-substituted 1-4C-alkoxy, and R3 stands for phenyl, pyridyl, R31, R32 and R33-substituted phenyl or R34, R35, R36 and R37-substituted pyridyl, in which R31 stands for hydroxy, halogen, cyano, carboxyl, trifluoromethyl 1-4C-alkyl, 1-4C-alkoxy, 1-4C-alkoxycarbonyl, 1-4C-alkylcarbonyl, 1-4C-alkylcarbonyloxy, amino, mono- or di-1-4C-alkylamino or 1-4C-alkylcarbonylamino; R32 stands for hydrogen, hydroxy, halogen, amino, trifluoromethyl, 1-4C-alkyl or 1-4C-alkoxy; R33 stands for hydrogen, halogen, 1-4C-alkyl or 1-4C-alkoxy; R34 stands for hydroxy, halogen, cyano, carboxyl, 1-4C-alkyl, 1-4C-alkoxy, 1-4C-alkoxycarbonyl or amino; R35 stands for hydrogen, halogen, amino or 1-4C-alkyl; R36 stands for hydrogen or halogen; and R37 stands for hydrogen or halogen. These compounds constitute new effective bronchotherapeutic drugs.
Patent PL-329109-A1 (PL)
Title: Method of modulating the synthesis of melanin
Inventor: GILCHREST BARBARA A
IPC: D06L3/00
Filed: 1997-03-27
Abstract: Methods are described whereby vertebrate skin, hair, wool or fur may be lightened, or darkened, in color by administration of a substance, e.g., peptide, antibody, antibody fragment or DNA sequence encoding a peptide, that modulates the protein kinase C-beta-mediated activation of tyrosinase, the rate-limiting enzyme in melanogenesis.
Patent PL-331798-A1 (PL)
Title: Semi-synthetic sulphaminoheparosane sulphate of high antimetastatic activity and reduced haemorhage risk and antimetastatic drugs
Inventor: NAGGI ANNAMARIA
IPC: A61P35/04
Filed: 1997-08-28
Abstract: Sulphaminoheparosansulphates obtainable from the Escherichia coli K5 polysaccharide by deacetilation and the subsequent sulfation with the sulphuric anhydride/trimethylamine adduct carried out at 0  DEG C, for times ranging from 0.25 to 2 hours and using a reactant/polysaccharide ratio (SO3 equivalents/available OH groups equivalents) equal to 5 have been found having high anti-metastatic activity and low anticoagulant activity.
Patent PL-346360-A1 (PL)
Title: Method for tuning the bandwidth of a phase-locked loop
Inventor: NILSSON LEIF MAGNUS ANDRE
IPC: H03L7/093
Filed: 1999-06-02
Abstract: A phase-locked loop bandwidth is tuned to a desired level by operating the phase-locked loop in a phase-locked condition at a first frequency and applying a step response to the phase-locked loop by causing the phase-locked loop to begin locking to a second frequency that is different from the first frequency. A parameter is then detected that is related to the applied step response and that is indicative of whether the phase-locked loop bandwidth is at the desired level. The phase-locked loop bandwidth is adjusted, and the steps of operating at the first frequency, applying the step response, detecting the parameter and adjusting the phase-locked loop bandwidth are repeated until the phase-locked loop bandwidth is at the desired level. Where the desired bandwidth level for tuning is not the operational bandwidth, the phase-locked loop bandwidth is further adjusted by a predetermined amount, thereby tuning the phase-locked loop bandwidth to an operational level. The step response may be applied by changing a frequency division value in a feedback path of the phase-locked loop. The detected parameter may be a pulse skip, which indicates that the bandwidth of the phase-locked loop is not yet at the desired bandwidth level.
Patent PL-349490-A1 (PL)
Title: Baby food stimulating growth of the thymus
Inventor: SAWATZKI GUENTHER
IPC: A23L33/18
Filed: 1999-12-07
Abstract: A thymus growth stimulating baby food is provided, substantially composed of a fat component, as well as a carbohydrate component and a protein component of animal or vegetable or animal and vegetable but not human origin, whereby the protein component is composed of intact proteins, hydrolyzed proteins, peptides or the constituents thereof, or of amino acids or a mixture thereof not bound to peptides or proteins. This type of baby food is characterized in that the total amount of arginine is at least 3.7 g per 100 g of the amino acids present in toto, and that it contains zinc (calculated as elementary zinc) in an amount of at least 40 mg per 100 g of the amino acids present in toto.
Patent PL-353396-A1 (PL)
Title: Metal fastening element
Inventor: FRISCHMANN ALBERT
IPC: F16B13/06
Filed: 2000-06-17
Abstract: The invention relates to a fastening element made from metal, having an expansion sleeve (2) and an expansion member (3), which expansion member (3) is axially displaceable on the shank of a threaded bolt (8), the threaded bolt (8) having on its forward end an end-stop in the form of an expander (9). On the threaded bolt (8), between the expander (9) and the expansion member (3), there is arranged a spacing element (10). In the event of a tensile load, the expander (9) enters the spacing element (10) and forms a deformation zone that corresponds to the length of the spacing element (10). As a result of the friction and deformation occurring in the deformation zone, overloads are absorbed and, consequently, the fastening element is prevented from coming out or the threaded bolt from breaking off.
Patent PL-360853-A1 (PL)
Title: Mineral wool product and manufacturing method
Inventor: BIHY LOTHAR
IPC: E04B1/74
Filed: 2001-09-06
Abstract: This invention relates to a mineral wool product (2) having a mineral wool body which is preferably shaped as a rectangular parallelepiped and which contains binder and mineral wool fibres, and has a surface layer which delimits the mineral wool body and contains binder and mineral wool fibres, as well as a method and a device for producing such mineral wool products (2), the mineral wool product (2) being provided in a surface zone at least on one side of the mineral wool body surface, directly in and/or under the surface layer (22) and/or by means of imparting a structure to the surface layer (22), with a mark (20), the mark (20) being introduced into the surface zone of the mineral wool body before and/or during complete curing of the binder, so that when the mineral fibres crosslink under the influence of the binder, the mark is connected firmly with the mineral wool body.
Patent PL-368346-A1 (PL)
Title: Powder processing with pressurized gaseous fluids
Inventor: SAIM SAID
IPC: A61K9/28
Filed: 2002-10-10
Abstract: Disclosed is a method of small particle precipitation, retention and dispersion of a solid or semi-solid material onto or into a carrier material. In this method, solute particles are precipitated from a pressurized gaseous fluid solution or a liquid solution and effectively retained and dispersed within a carrier material. This technique can be advantageously used in pharmaceutical processing to produce a blend of solid or semi-solid material particles and carrier material, a granulation of the solid or semi-solid material particles with carrier material, carrier material partially or fully coated with the solid or semi-solid material particles, or mixtures thereof.
Patent PL-371209-A1 (PL)
Title: Heat exchanger for a refrigerating appliance and method for producing a heat exchanger
Inventor: CIESLIK DETLEF
IPC: F28D1/047
Filed: 2003-04-25
Abstract: A heat exchanger for a refrigerating appliance includes a plate, a conduit tubing, which is placed in thermo-conductive contact with the plate and is provided for transporting a coolant, and a holding material layer that adheres to the plate and to the conduit tubing. The holding material layer is made of a bitumen composition. The heat exchanger can be produced by stacking the plate, the conduit tubing, and a sheet made of the bitumen composition, whereby the holding material layer is formed form the sheet by heating and pressing the stack.
Patent PL-377337-A1 (PL)
Title: Humanized antibody (h14.18) of the mouse 14.18 antibody binding to gd2 and its fusion with il-2
Inventor: GILLIES STEPHEN D
IPC: A61K48/00
Filed: 2003-12-16
Abstract: The invention provides a family of antibodies that specifically bind the human cell surface glycosphingolipid GD2. The antibodies comprise modified variable regions, more specially, modified framework regions, which reduce their immunogenicity when administered to a human. The antibodies may be coupled to a therapeutic agent and used in the treatment of cancer.
Patent PL-378806-A1 (PL)
Title: Therapeutic patch with polysiloxane matrix comprising capsaicin
Inventor: MUELLER WALTER
IPC: A61K9/70
Filed: 2003-11-19
Abstract: The invention relates to a topical patch comprising a therapeutic compound-impermeable backing layer, a self-adhesive matrix based on polysiloxanes and containing capsaicin or a therapeutic compound analogous to capsaicin, and a protective film to be removed before use, in which the matrix contains liquid microreservoirs based on an amphiphilic solvent, in which the therapeutic compound is present in completely dissolved form and the concentration of the therapeutic compound in the microreservoir droplets is below the saturation concentration. The invention furthermore relates to a process for its production and its use in the treatment of neuropathic pain.
Patent PL-396480-A1 (PL)
Inventor: AMBROZIAK WOJCIECH
IPC: A23L29/20
Filed: 2011-09-30
Abstract: Sposób wytwarzania sosów, zeli i substancji zageszczajacych charakteryzuje sie tym, ze dodaje sie enzym transglutaminazy w ilosci nie mniejszej niz 0,05% korzystnie 0,1-0,3% w stosunku do masy surowca, przy pH -produktu mieszczacego sie w zakresie od 3 do 9, korzystnie pH 5-7, w temperaturze od 4 do 80°C, korzystnie 45-55°C do mieszaniny przecieru, i/lub kremogenu, i/lub puree i/lub rozdrobnionych warzyw, i/lub owoców, i/lub grzybów, i/lub ich polaczenia, swiezych i/lub utrwalonych metodami biologicznymi, fizycznymi wzglednie chemicznymi oraz z innymi typowymi dla sosów, zeli i substancji zageszczajacych dodatkami, nastepnie calosc miesza sie, konfekcjonuje i pasteryzuje w znany sposób.